5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like Frazier-Backed Mavupharma Scores $20M to Fund STING Program November 28, 2017 A Look at Gilead's Possible New Drug Strategy May 30, 2017 Confident Johnson & Johnson Flexes Its Muscles, Plans 10 Blockbuster Approvals by 2021 May 16, 2017